About
Contact & Profiles
A5028887349
Research Areas
- Autoimmune Neurological Disorders and Treatments
- Peripheral Neuropathies and Disorders
- Parvovirus B19 Infection Studies
- Otitis Media and Relapsing Polychondritis
- Pharmacological Receptor Mechanisms and Effects
- Neurological disorders and treatments
- CNS Lymphoma Diagnosis and Treatment
- Systemic Lupus Erythematosus Research
- Multiple Sclerosis Research Studies
- Cancer Immunotherapy and Biomarkers
- Polyomavirus and related diseases
- Brain Metastases and Treatment
- Genetic Neurodegenerative Diseases
- Viral-associated cancers and disorders
University of Colorado Health
2024-2025
University of Cincinnati
2023
University of Cincinnati Medical Center
2019-2021
10.1212/wnl.0000000000212214
article
EN
Neurology
2025-04-07
10.1016/j.msard.2021.102964
article
EN
Multiple Sclerosis and Related Disorders
2021-04-21
To evaluate the frequency of neurological-immune-related adverse events (n-irAES) and associated demographic/clinical characteristics oncological patients treated with immune-checkpoint inhibitors (ICIs) at University Cincinnati (UC).
10.1212/wnl.0000000000205406
article
EN
Neurology
2024-04-09
10.1212/wnl.96.15_supplement.1573
article
EN
Neurology
2021-04-13
Coming Soon ...